CA2384046A1 - Method for improving and maintaining bowel function as well as a method for the production thereof - Google Patents

Method for improving and maintaining bowel function as well as a method for the production thereof Download PDF

Info

Publication number
CA2384046A1
CA2384046A1 CA002384046A CA2384046A CA2384046A1 CA 2384046 A1 CA2384046 A1 CA 2384046A1 CA 002384046 A CA002384046 A CA 002384046A CA 2384046 A CA2384046 A CA 2384046A CA 2384046 A1 CA2384046 A1 CA 2384046A1
Authority
CA
Canada
Prior art keywords
composition
intestine
compound
improving
laxatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002384046A
Other languages
English (en)
French (fr)
Inventor
Gunther Beisel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE29915668U external-priority patent/DE29915668U1/de
Priority claimed from DE1999142424 external-priority patent/DE19942424A1/de
Application filed by Individual filed Critical Individual
Publication of CA2384046A1 publication Critical patent/CA2384046A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002384046A 1999-09-06 2000-09-05 Method for improving and maintaining bowel function as well as a method for the production thereof Abandoned CA2384046A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE29915668U DE29915668U1 (de) 1999-09-06 1999-09-06 Mittel zur Verbesserung und Erhaltung der Darmtätigkeit
DE19942424.1 1999-09-06
DE29915668.0 1999-09-06
DE1999142424 DE19942424A1 (de) 1999-09-06 1999-09-06 Mittel zur Verbesserung und Erhaltung der Darmtätigkeit sowie Verfahren zu dessen Herstellung
PCT/EP2000/008645 WO2001017509A1 (de) 1999-09-06 2000-09-05 Mittel zur verbesserung und erhaltung der darmtätigkeit sowie verfahren zu dessen herstellung

Publications (1)

Publication Number Publication Date
CA2384046A1 true CA2384046A1 (en) 2001-03-15

Family

ID=26054843

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002384046A Abandoned CA2384046A1 (en) 1999-09-06 2000-09-05 Method for improving and maintaining bowel function as well as a method for the production thereof

Country Status (4)

Country Link
EP (1) EP1210071A1 (de)
AU (1) AU7284300A (de)
CA (1) CA2384046A1 (de)
WO (1) WO2001017509A1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2767562A4 (de) * 2011-10-11 2015-08-12 Nissan Chemical Ind Ltd Zusammensetzung zur bildung eines gehärteten films, orientierungsmaterial und phasendifferenzmaterial

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040071779A1 (en) * 2002-10-09 2004-04-15 Keiser Dale Arthur Gelled laxative compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1302548A (de) * 1969-07-28 1973-01-10
GB8518301D0 (en) * 1985-07-19 1985-08-29 Fujisawa Pharmaceutical Co Hydrodynamically explosive systems
DE59610768D1 (de) * 1996-09-07 2003-11-13 Guenther Beisel Mittel mit retardwirkung
BR9713303A (pt) * 1996-11-27 2000-03-21 Guenther Beisel Agente para preparação de um efeito de satisfação prolongado
WO1998026767A2 (en) * 1996-12-17 1998-06-25 Poli Industria Chimica S.P.A. Site-specific controlled release dosage formulation for mesalamine
DE19739031A1 (de) * 1997-09-05 1999-03-11 Suwelack Nachf Dr Otto Mittel zur peroralen Verabreichung, seine Herstellung und Verwendung
DE29915656U1 (de) * 1999-09-06 2000-04-20 Beisel Guenther Vernetztes Mittel zur Erzeugung eines langanhaltenden Sättigungseffekts
DE29915634U1 (de) * 1999-09-06 2000-05-25 Beisel Guenther Mittel zur Stimulanz der Darmtätigkeit

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2767562A4 (de) * 2011-10-11 2015-08-12 Nissan Chemical Ind Ltd Zusammensetzung zur bildung eines gehärteten films, orientierungsmaterial und phasendifferenzmaterial

Also Published As

Publication number Publication date
WO2001017509A1 (de) 2001-03-15
AU7284300A (en) 2001-04-10
EP1210071A1 (de) 2002-06-05

Similar Documents

Publication Publication Date Title
US6677318B1 (en) Cross-linked agent for generation of a long-lasting satiety effect and method for the production of the said
US20230416489A1 (en) Polymer compositions
Kaushik et al. Role of excipients and polymeric advancements in preparation of floating drug delivery systems
CZ2001230A3 (en) Polymeric complexes of glucuronoglucans
JP2006518392A (ja) 胃腸管または泌尿生殖器官エリアのための自己膨張性デバイス
AU778178B2 (en) Cross-linked agent for generation of a long-lasting satiety effect and method for the production of the said
US6541031B1 (en) Composition with release-controlling action
DE19942417A1 (de) Vernetztes Mittel zur Erzeugung eines langanhaltenden Sättigungseffekts und Verfahren zu dessen Herstellung
CA2384046A1 (en) Method for improving and maintaining bowel function as well as a method for the production thereof
WO1998023259A1 (de) Mittel zur erzeugung eines langanhaltenden sättigungseffekts
Setia et al. Applications of gum karaya in drug delivery systems: a review on recent research
Gayakwad et al. Natural Polymers In The Development Of Gastroretentive Systems: A Review
CN1738653A (zh) 制备海绵状材料的方法
CA2383996A1 (en) Agent for stimulating bowel function and method for producing the same
DE19942424A1 (de) Mittel zur Verbesserung und Erhaltung der Darmtätigkeit sowie Verfahren zu dessen Herstellung
EP1572256A2 (de) Verfahren zur herstellung von schwammartigen materialien
Hamman Development of multiple-unit pellet systems by employing the SeDeM expert diagram system
DE10259504A1 (de) Verfahren zur Herstellung eines oral einnehmbaren Mittels enthaltend schwammartige Materialien
DE10247910A1 (de) Mittel zur Erzeugung eines langanhaltenden Sättigungseffektes
DE19942365A1 (de) Mittel zur Stimulanz der Darmtätigkeit sowie Verfahren zu dessen Herstellung
MXPA99004913A (en) Agent for producing a long-lasting saturation effect
Shiv Design and evaluation of floating drug delivery system for antimicrobial drug
Gannamaneedi Comparative Evaluation of Wax Incorporated Alginate and Pectinate Gel Beads Using Metformin as a Model Drug
JP2001510460A (ja) 長時間持続する満腹効果を生み出すための材料

Legal Events

Date Code Title Description
FZDE Dead